Ketonal Prolong (Ketoprofen)

Ketoprofen blocks the activity of both COX‑1 and COX‑2 enzymes, which are essential for producing prostaglandins that sensitize nerve endings and promote inflammation. By lowering prostaglandin levels, ketoprofen reduces peripheral nerve sensitisation, thereby decreasing pain signals and diminishing swelling and redness at the site of injury.

The appropriate dose of Ketonal Prolong is determined by the prescribing clinician based on the patient’s age, weight, medical condition, and response to therapy. Healthcare professionals tailor the regimen to achieve effective pain control while minimising potential adverse effects, and patients should follow the specific instructions provided on the prescription label.

Ketoprofen, like other NSAIDs, is generally avoided in the third trimester of pregnancy because it may affect fetal circulation and prolong labor. Safety during earlier stages of pregnancy and while breastfeeding has not been definitively established, so clinicians usually weigh the benefits against potential risks before prescribing it to pregnant or lactating women.

To request Ketonal Prolong, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Ketonal Prolong (ketoprofen) offers a balanced profile of analgesic and anti‑inflammatory activity, similar to ibuprofen and naproxen, but it may provide stronger pain relief in some musculoskeletal conditions. Its non‑selective COX inhibition can lead to a comparable gastrointestinal risk, so clinicians consider patient history and co‑medications when choosing between ketoprofen and other NSAIDs.

Ketonal Prolong should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Ketonal Prolong is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with meals may reduce the likelihood of gastrointestinal discomfort. Patients should swallow the tablet whole and not split, crush, or chew it unless directed otherwise by a healthcare professional.

The most serious risks include gastrointestinal ulceration or bleeding, severe skin reactions such as Stevens‑Johnson syndrome, and renal impairment that can lead to reduced kidney function. Patients should be monitored for signs of abdominal pain, blood in stool, rash, or sudden changes in urine output, and they should seek medical attention promptly if these occur.

Ketonal Prolong should be avoided in individuals with a known hypersensitivity to ketoprofen or other NSAIDs, those with active gastrointestinal ulcers or bleeding, severe renal or hepatic impairment, and patients in the third trimester of pregnancy. Additionally, patients taking anticoagulants, other NSAIDs, or SSRIs should discuss alternative therapies with their prescriber.